Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.004 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.009 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |